Received: 14 February 2020
Accepted: 6 April 2020
First Online: 5 June 2020
Compliance with Ethical Standards
: The NIDCR receives financial support from QED Pharma to study BGJ398 in tumor-induced osteomalacia. The Pontificia Universidad Católica de Chile (PF, MJ) receives research support from Ultragenyx Pharmaceutical, Inc. for research related to hypophosphatemic rickets. Work in the Laboratories of IH, KR, RG, MC is supported by the Intramural Research Program of the NIH, NIDCR.